Beyond the Gold Standard: Advancing Axillary Staging with SPIO

Sentinel lymph node biopsy (SLNB) using radioisotope and blue dye is widely considered the “gold standard” for axillary staging – but does it offer everything we need in increasingly complex breast cancer pathways?

This webinar will explore how the SPIO can expand what’s possible in axillary staging, from neoadjuvant settings to delayed SLNB and beyond.

At the end of the webinar, participants will have a better view on how to benefit from a more flexible, accurate and patient-centred approach for axillary staging.